The Global Burden of Disease (GBD) study is a powerful tool for informing public health strategies and policies. Its comprehensive and regularly updated database enables comparisons across health states, regions, and years. However, certain methodological features, combined with the study’s considerable influence, may inadvertently contribute to the neglect of conditions that are critical to population health. This Editorial highlights the underrepresentation of sleep disorders in current disease burden research, notably the GBD study.
A substantial body of evidence demonstrates that restorative sleep is essential for mental, physical, and societal wellbeing, as well as economic prosperity [1]. Sleep health is now recognized as a major determinant of overall health. For instance, recent research drawing on more than 380,000 participants from the UK Biobank indicates that healthy sleep patterns, such as maintaining a sleep duration of 7–8 h per night, are associated with reduced risks of both overall and site-specific cancers [2]. Concerningly, sleep disturbances are highly prevalent: approximately 25% of the population reports reduced sleep duration (sleep loss) [3], and 10% experience excessive daytime sleepiness [4]. Sleep disorders that reach a clinically significant threshold are also common. For example, severe insomnia affects approximately 8% of the general population [5], and sleep apnea occurs in 9%–38% of adults [6].
Despite this considerable burden, sleep disorders have been absent from GBD publications since the 2004 update [7]. They are currently neither included as primary disorders nor as risk factors [8]. Consequently, key burden metrics such as disability-adjusted life years (DALYs) remain underreported for conditions of inadequate sleep. This gap is notable given that many rare diseases, symptoms, and risk factors are routinely included in GBD analyses. The reason for the exclusion of sleep disorders is unknown to the authors of this Editorial, also considering that GBD estimations could be informed by primary data from large epidemiological resources, such as the UK Biobank [2].
The exclusion of sleep disorders from multi-disease burden reports such as the GBD study has important implications. As these estimates are widely used to derive prevention and healthcare needs, the exclusion of sleep disorders perpetuates their inadequate management across sectors, including prevention, diagnosis, and treatment. This is particularly concerning because improvements in sleep quality and consistency have beneficial spillover effects on mental, neurological, cardiovascular, and metabolic outcomes as well as on overall health [1]. Inadequate sleep also poses a direct threat to population health and safety by increasing the risk of traffic accidents [9]. A recent GBD publication acknowledges that, “Psychosocial factors, such as sleep, stress, and social isolation, are increasingly recognized as contributors to neurological conditions and should be quantified in future analyses.” [10]. While we welcome the inclusion of sleep as a determinant of health, we argue that sleep disorders should also be recognized as primary disorders, as reflected in current disease classification systems, including the DSM-5 and ICD-11.
Through this Editorial, we aim to alert policymakers, clinicians, and researchers to the significant gap in burden data on sleep disorders–a gap that limits evidence-based prevention and healthcare strategies. Incorporating sleep disorders into burden estimation frameworks, such as the GBD study, would enhance disease recognition and represent a critical step toward improving population health.
Statements
Author contributions
CB: Data curation. LW, CN, BR, RH, AD, EP, MB, VS, and CB. Project administration: CB, LW. Supervision: CB. Validation: LW, CN, BR, RH, AD, EP, MB, VS, and CB. Writing – original draft: LW. Writing – review and editing: LW, CN, BR, RH, AD, EP, MB, VS, and CB. All authors contributed to the article and approved the submitted version.
Funding
The author(s) declared that financial support was received for the research and/or publication of this article. The authors’ listed affiliations covered the publication fee.
Conflict of interest
The authors declare that they do not have any conflicts of interest.
Generative AI statement
The author(s) declared that generative AI was used in the creation of this manuscript. Exclusively to improve wording, ChatGPT was used in this article. No artificial intelligence was used for the research and development of ideas presented in this work.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
References
1.
RamarKMalhotraRKCardenKAMartinJLAbbasi-FeinbergFAuroraRNet alSleep Is Essential to Health: An American Academy of Sleep Medicine Position Statement. J Clin Sleep Med (2021) 17(10):2115–9. 10.5664/jcsm.9476
2.
ZhaoYZZhangWLZhangKWHeYQXueWQYangDWet alSleep Pattern, Lifestyle Pattern, and Risks of Overall and 20 Types of Cancers: Findings From the UK Biobank Cohort. Int J Public Health (2025) 69:1607726. 10.3389/ijph.2024.1607726
3.
KocevskaDLysenTSDotingaAKoopman-VerhoeffMELuijkMPCMAntypaNet alSleep Characteristics Across the Lifespan in 1.1 Million People from the Netherlands, United Kingdom and United States: A Systematic Review and Meta-Analysis. Nat Hum Behav (2021) 5(1):113–22. 10.1038/s41562-020-00965-x
4.
MorinCMJarrinDC. Epidemiology of Insomnia: Prevalence, Course, Risk Factors, and Public Health Burden. Sleep Med Clin (2022) 17(2):173–91. 10.1016/j.jsmc.2022.03.003
5.
BenjafieldAVSert KuniyoshiFHMalhotraAMartinJLMorinCMMaurerLFet alEstimation of the Global Prevalence and Burden of Insomnia: A Systematic Literature Review-Based Analysis. Sleep Med Rev (2025) 82:102121. 10.1016/j.smrv.2025.102121
6.
SenaratnaCVPerretJLLodgeCJLoweAJCampbellBEMathesonMCet alPrevalence of Obstructive Sleep Apnea in the General Population: A Systematic Review. Sleep Med Rev (2017) 34:70–81. 10.1016/j.smrv.2016.07.002
7.
MathersCFatDMBoermaJT, editors. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva: World Health Organization (2008).
8.
HaySIOngKLSantomauroDFAalipourMAAalruzHet alBurden of 375 Diseases and Injuries, Risk-Attributable Burden of 88 Risk Factors, and Healthy Life Expectancy in 204 Countries and Territories, Including 660 Subnational Locations, 1990–2023: A Systematic Analysis for the Global Burden of Disease Study 2023. The Lancet (2025) 406(10513):1873–922. 10.1016/S0140-6736(25)01637-X
9.
BioulacSMicoulaud-FranchiJAArnaudMSagaspePMooreNSalvoFet alRisk of Motor Vehicle Accidents Related to Sleepiness at the Wheel: A Systematic Review and Meta-Analysis. Sleep (2017) 40(10). 10.1093/sleep/zsx134
10.
GBD 2021 Nervous System Disorders Collaborators. Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021. Lancet Neurol (2024) 23(4):344–81. 10.1016/S1474-4422(24)00038-3
Summary
Keywords
disability-adjusted life years, disease burden, global burden of disease, public health, sleep disorders
Citation
Welter LS, Nissen C, Rasch B, Heinzer R, Datta AN, Piovesana E, Bouvier Gallacchi M, Sterpenich V and Bassetti CLA (2026) Sleep Disorders: A Blind Spot in Disease Burden Research. Int. J. Public Health 71:1609757. doi: 10.3389/ijph.2026.1609757
Received
12 March 2026
Revised
27 March 2026
Accepted
13 April 2026
Published
06 May 2026
Volume
71 - 2026
Edited by
Nino Kuenzli, Swiss Tropical and Public Health Institute (Swiss TPH), Switzerland
Updates
Copyright
© 2026 Welter, Nissen, Rasch, Heinzer, Datta, Piovesana, Bouvier Gallacchi, Sterpenich and Bassetti.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Luisa Sophie Welter, welter.psy@web.de
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.